Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Invokana (canagliflozin) for the Treatment of Type 2 Diabetes

Drug Name (Brand / Generic)

Invokana / canagliflozin

Company / Licensee

Janssen Pharmaceuticals / Mitsubishi Tanabe Pharma Corporation

Product Description

Sodium glucose co-transporter 2 (SGLT2) inhibitor

Current Indication

Type 2 Diabetes

Market Sector

Diabetes

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top